![]() |
|
|
Vol. 52, Issue 6, 1064-1070, 1997
q or G
o Proteins in
1-Adrenoceptor Subtype-Mediated Responses in Fischer 344 Rat Aorta
Department of Pharmacology, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania (H.G., T.S., H.Y.W., M.D.J., E.F.), Department of Pharmacology, the Medical School of Ankara University Ankara, Turkey (H.G.), and Research and Development Service, Edward Hines Jr. Veterans' Administration Hospital, Hines, Illinois (R.D.B.)
| |
Summary |
|---|
|
|
|---|
Previous studies showed that
-adrenoceptor (AR) stimulation with
norepinephrine is more potent at eliciting contraction in aortas from
1-month-old Fischer 344 rats than from older rats and that this
response is mediated by
1b- and
1d-AR
subtypes in 1-month-old rats. We examined the G proteins responsible
for
1-AR-mediated contractile response and inositol
phosphate accumulation in the aortas of 1-month-old Fischer 344 rats.
Pertussis toxin (PTX) treatment (2.5 µg/ml for 4 hr) of aortic rings
partially inhibited phenylephrine (PHE)-stimulated contraction and
inositol phosphate accumulation, suggesting the involvement of
PTX-sensitive and -insensitive G proteins. Specific antisera directed
against G
q and G
o but not
G
s and G
i precipitated specific
1-AR binding sites labeled with
2-[
-(4-hydroxy-3-[125I]iodophenyl)ethylaminomethyl]tetralone.
The number of
2-[
-(4-hydroxy-3-[125I]iodophenyl)ethylaminomethyl]tetralone
binding sites precipitated by G
proteins was increased
by activating membrane
1-ARs with PHE. Moreover, PHE
stimulated the palmitoylation of G
q and
G
o, and this response was blocked by the
1-AR antagonist prazosin. Characterization of the
1-AR subtypes that couple to G proteins indicates that
although aortic
1a-,
1b-, and
1d-ARs were associated with G
q,
1b-AR was also linked to G
o. These
results suggest that
1-ARs mediate the contractile
response in rat aorta by coupling to both Gq protein and
the PTX-sensitive Go protein.
| |
Introduction |
|---|
|
|
|---|
Three
1-AR subtypes (
1a,
1b, and
1d) have been
cloned, and mRNA for each has been detected in the rat aorta (1, 2). The specific role of each
1-AR subtype in
regulating vascular smooth muscle function has not been completely
established. When overexpressed in cultured cells, each of the subtypes
has been shown to be capable of eliciting characteristic
1-adrenergic responses, including activation
of PLC and increased intracellular calcium (3, 4). Several studies have
shown that
1-ARs can couple to
Gq and activate phospholipase C, resulting in
production of inositol trisphosphate and release of intracellular
calcium (5). However, it has been shown that
1-AR-mediated contractile responses in
vascular smooth muscle are partially inhibited by PTX treatment,
suggesting the involvement of both PTX-sensitive and -insensitive G
proteins in the contractile response (6-8). Thus, in vascular smooth
muscle, it is not clear what combination of endogenous
1-AR subtypes and G proteins is responsible
for activating PLC and eliciting the contractile response.
In previous studies, we showed that although aortas from 1-month-old
Fischer 344 rats express
1a-,
1b-, and
1d-ARs, the contractile response to NE is mediated by stimulation of the
1b- and
1d-ARs (9,
10). NE produced a more potent contractile response in these aortas
compared with aortas of older rats, in which the expression and
functional role of the
1a-AR increase (9, 11).
The determination of the coupling of
1-AR
subtypes to specific G proteins will facilitate understanding of the
functional roles of
1-AR subtypes in the
aorta; therefore, the aim of the current study was to define
1-AR/G protein coupling in aortic membranes.
This was achieved by examining the sensitivity of
1-AR-mediated responses to PTX treatment;
assessing
1-ARs that coimmunoprecipitated with
G
proteins using specific antisera directed
against G
subunits, G
proteins that coimmunoprecipitated with
1-AR
subtypes using specific antisera directed against
1-AR subtypes; and examining
1-AR-stimulated palmitoylation of
subunits or receptor-stimulated changes in coprecipitation of
1-AR binding sites with
G
subunits in aortic membranes.
| |
Experimental Procedures |
|---|
|
|
|---|
Animals. One-month-old male Fischer 344 rats were obtained from National Center for Toxicological Research (Jefferson, AR), where they are bred and maintained under the auspices of the National Institute on Aging. On receipt at our institution, animals were maintained for 1-2 weeks under barrier conditions comparable to those under which they were raised.
Contraction. Rats were killed through decapitation, and the aorta was removed and placed in ice-cold PSS composed of 120 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl2, 1.0 mM NaH2PO4, 25 mM NaCO3, 1.8 mM CaCl2, 11 mM glucose, and 0.024 mM EDTA. Vessels were cleansed of fat and connective tissue and cut into 3-mm-wide rings. Aortic ring segments were mounted at 37° in 15-ml organ baths using stainless steel hooks connected by fine gold chain at the bottom to a stationary glass rod attached to the bath and at the top to a Grass Instruments (Quincy, MA) model FT0.03 force-displacement transducer and bubbled continuously with 95% O2/5% CO2. Responses were recorded on a Grass model 7 polygraph. Rings were equilibrated for 1 hr at a previously optimal resting tension of 1.5 g. Concentration-response curves were determined through cumulative increases in the concentration of agonist. Rings then were washed extensively by several changes of PSS over 1-2 hr until tension stabilized at the precontraction level. For experiments with PTX, rings were incubated with the toxin for 4 hr in PSS. Then, the rings were washed for 1 hr with several changes of PSS, and cumulative concentration-response curves to PHE were obtained.
IP accumulation. The method used for measuring [3H]inositol metabolism was described previously (12, 13). Aortic rings were prepared as described above and then preincubated in oxygenated buffer composed of 122 mM NaCl, 4.9 mM KCl, 1.2 mM MgCl2, 1.2 mM KH2PO4, 3.6 mM NaCO3, 1.3 mM CaCl2, 11 mM glucose, and 30 mM HEPES, pH 7.4, at 37° for 1 hr. Subsequently, artery segments were incubated for 1.5 hr in buffer containing 20 µCi/ml of myo-[3H]inositol (17 Ci/mmol; New England Nuclear Research Products, Boston, MA) under the same conditions. Labeled artery segments were washed four times and placed inot individual tubes containing buffer with 10 mM LiCl (total assay volume, 300 µl). Treatment with PTX was as described above. Incubation with agonist was for 60 min with oxygenation at 15-min intervals and was stopped by the addition of 300 µl of ice-cold 15% trichloroacetic acid and then left on ice for 15 min. The tubes were centrifuged (1500 × g for 10 min), and aliquots (350 µl) of supernatant were added to 125 µl of 10 mM EDTA in 1.5-ml microcentrifuge tubes, followed by 500 µl of 1:1 Freon/tri-n-octylamine. The samples were vortexed and left to stand for 10 min before centrifugation (12,000 × g for 10 min), and 350 µl of upper aqueous phase was taken for analysis of IPs. Samples were loaded onto Dowex-1(X8) ion exchange columns (formate form, 100-200 mesh, 1 ml). The columns were washed initially with 16 ml of myo-[3H]inositol (5 mM). Then, IPs were eluted with 4 ml of 0.1 M formic acid/1 M ammonium formate. Radioactivity was measured by liquid scintillation counting.
Preparation of aortic membrane. Rats were killed by decapitation, and the aorta was removed; placed in 20 mM NaH2PO4-Na2HPO4 buffer (pH 7.6) containing 154 mM NaCl, 0.5 mM phenylmethylsulfonyl fluoride, 25 µg/ml leupeptin, 20 µg/ml aprotinin, and 25 µg/ml pepstatin; cleansed of fat and connective tissue; homogenized using a glass-to-glass homogenizer; and centrifuged at 500 × g for 10 min at 4°. The supernatant was centrifuged at 100,000 × g for 60 min at 4°. The resulting pellet was resuspended, rehomogenized, and then recentrifuged under the same conditions. The final pellet was resuspended in PBS. Protein content was measured according to the method of Bradford (14).
Solubilization of aortic membrane.
Aortic membranes were
solubilized by modification of a previously described procedure (15).
Briefly, aortic membranes were prepared as described above. They were
then solubilized by gentle end-over-end shaking for 60 min at 4° in
PBS containing 1.5% digitonin, 0.5 mM phenylmethylsulfonyl
fluoride, 25 µg/ml leupeptin, 20 µg/ml aprotinin, and 25 µg/ml
pepstatin. The sample was centrifuged at 100,000 × g
for 60 min at 4°, and the supernatant was used for the soluble
fraction of the membrane. The pellet was also collected for
determination of the insoluble
1-ARs and G
protein
subunits remaining in the membranes. The solubilized
1-ARs were detected by measuring
[125I]HEAT binding. The samples were incubated
with a 300-400 pM concentration of
[125I]HEAT for 60 min at 37°. Reactions were
terminated by rapid filtration using a Brandel (Montreal, Quebec,
Canada) cell harvester and Whatman (Clifton, NJ) DE81 filters to trap
the solubilized proteins. Filters were washed four times with 4 ml of
ice-cold PBS. The filter-bound radioactivity was determined in a
Beckman Instruments (Palo Alto, CA)
-counter. Nonspecific binding
was defined as binding in the presence of 0.1 µM prazosin
or 1 mM NE with identical results. Assays were conducted in
duplicate. After solubilization of aortic membranes, 20-30% of the
initial
1-AR binding was detected in soluble
fraction.
Immunoprecipitation of G protein
subunits and
1-AR subtypes.
Solubilized G protein
subunits
were immunoprecipitated as described previously (15, 16). Soluble
membrane protein (10-15 fmol of
1-AR) was
incubated with an appropriate dilution of
G
-specific antiserum overnight in a rotatory
shaker at 4°C. Nonimmune serum at the same dilution was used as a
control. Appropriate dilution was determined when no further
immunoprecipitation was observed at a higher concentration of the
antiserum (maximum concentration, 1:50). Then, 100 µl of a 1:1
suspension of protein A/Sepharose beads (CL-4B: Sigma Chemical, St.
Louis, MO), prewashed three times and diluted in PBS, was added to the
samples and incubated overnight in a rotary shaker at 4°C. The
samples were centrifuged at 10,000 × g for 3 min; the
supernatant was collected to measure remaining
1-ARs; and the pellet
was resuspended in PBS and recentrifuged as described above. The
immunoprecipitate was resuspended in PBS, and
1-ARs were detected by measuring
[125I]HEAT binding as described above. In some
samples, the immunoprecipitate was separated on 10% SDS-polyacrylamide
gels, transferred to nitrocellulose membrane, and immunoblotted with
anti-G
antisera to confirm the identity of the
precipitated G protein
subunits. In several experiments, the
immunoprecipitate was incubated with 0.1 mM
guanosine-5
-(
,
-imido)triphosphate for 60 min at 25° and then
centrifuged at 10,000 × g for 3 min. The pellet was
resuspended in PBS, and
1-ARs in the
immunoprecipitate were determined using the radioligand binding assay
described above.
1a-,
1b-, or
1d-ARs (1:250 dilution) for 3 hr followed by a
60-min incubation with 100 µl of a 10% suspension of protein A,
bearing Staphylococcus aureus cells (Pansorbin cells;
Calbiochem, San Diego, CA). Initial characterization of these
antibodies has been reported previously (17). After centrifugation and
washing, the immunoprecipitates were solubilized in sample preparation buffer (62.5 mM Tris·HCl, pH 6.8, 10% glycerol, 2% SDS,
5% 2-mercaptoethanol, 0.1% bromphenol blue), and proteins were
separated by 10% SDS-polyacrylamide gel electrophoresis, transferred
electrophoretically to a nitrocellulose membrane, and immunoblotted
with polyclonal antibody against G
proteins
(1:2000 in 0.1% Tween-20 in PBS). In some samples, the selectivity of
the antisera directed against
1a-,
1b-, or
1d-ARs, and
the effectiveness of the immunoprecipitation was tested. The immunoprecipitates were separated on 10% SDS-polyacrylamide gels, transferred to nitrocellulose membranes, and immunoblotted with anti-
1a-, -
1b-, or
-
1d-AR antisera to test the identity and the
amount of the precipitated
1-AR subtype.
Immunoblots.
Aortic membranes, solubilized membranes, or
membrane immunoprecipitates were subjected to 10% SDS-polyacrylamide
gel electrophoresis (18) and then transferred electrophoretically to
nitrocellulose. Immunoblotting was performed using antisera for
subunits of G proteins [RM/1 (G
s), AS/7
(G
i), GC/2 (G
o), QL (G
q/11); dilution 1:2000; New Nuclear England
Research Products] and ECL as described previously (15, 19). Briefly,
nitrocellulose membranes were incubated overnight at 4° in PBS
containing 3% bovine serum albumin and 8% nonfat dry milk. Blots were
washed several times with 0.1% TBS and then incubated with antisera at room temperature for 1-2 hr with shaking. Blots were then washed four
times (10 min each) with 0.1% TBS and then incubated with 1:10,000
dilutions of horseradish peroxidase-labeled donkey anti-rabbit IgG or
rabbit anti-goat (
1a-AR) in 0.1% TBS for 1 hr
at room temperature. Blots were washed once with 0.3% TBS for 30 min
followed by four 5-min washes with 0.1% TBS and then incubated with
ECL Western blotting reagent (SuperSignal substrate, Western Blotting; Pierce, Rockford, IL) for 4 min and exposed to X-ray film for 15-45
sec.
Agonist-induced palmitoylation of G
proteins.
Aortas were homogenized and centrifuged (500 × g for
10 min at 4°) as described above except with HEPES buffer containing 25 mM HEPES, pH 7.4, and 2 mM EGTA. The
supernatant was centrifuged at 100,000 × g for 60 min
at 4°. The resulting pellet was resuspended, rehomogenized, and then
recentrifuged under the same conditions. The final pellet was
resuspended in oxygenated Krebs-HEPES buffer containing 25 mM HEPES, pH 7.4, 154 mM NaCl, 4.8 mM KCl, 1.2 mM KH2PO4, 1.2 mM
MgCl2, 0.2% 2-mercaptoethanol, 25 µg/ml
leupeptin, 25 µg/ml pepstatin A, 0.01unit/ml soybean trypsin
inhibitor, and 0.05 mM phenylmethylsulfonyl fluoride and
used as the crude membrane preparation. The assay mixture (250 µl)
containing 200 µg of membrane protein, 800 µCi/ml
[9,10-3H]palmitic acid (specific activity, 50 Ci/mmol; New Nuclear England Research Products) was incubated at 37°
for 10 min followed by an additional 5-min incubation with either
buffer or agonist. To test the specificity of this receptor mediated
response, membranes were incubated with a selective
1-AR antagonist for 5 min before the addition
of the agonist. The reaction was terminated by dilution with 750 µl
of ice-cold Krebs-HEPES containing 1 mM EGTA, mixed, placed
on ice, and immediately centrifuged at 16,000 × g for
30 min in microcentrifuge. The pellets were solubilized in 1.5 ml of
Krebs-HEPES buffer containing 1.5% digitonin, and soluble membrane proteins were immunoprecipitated using antisera directed against the
G
proteins as described above. The
radioactivity in the immunoprecipitate was measured by liquid
scintillation counting. The radioactivity precipitated by the normal
rabbit serum was considered background and subtracted from all values.
Data analysis. Differences were determined by ANOVA and post hoc analysis for multiple comparisons. A value of p < 0.05 was considered significant.
Materials.
For these studies, pargyline HCl, soybean trypsin
inhibitor, and the buffer reagents were purchased from Sigma. The
chemicals used for IP isolation and determination were purchased from
Fisher Scientific (Pittsburgh, PA). PHE was purchased from Research
Biochemicals (Natick, MA). Normal rabbit serum and Pansorbin were
purchased from Calbiochem. Prazosin HCl was generously supplied by
Pfizer (New York, NY). [9,10-3H]Palmitic acid
(50 Ci/mmol), [125I]HEAT (2200 Ci/mmol), and
the antisera to G
s (RM/1),
G
i(1,2) (AS/7), G
o
(GC/2), and G
q/11 (QL) were purchased from New
Nuclear England Research Products. Antisera to
1b- and
1d-ARs were
produced by one of the authors (R.D.B.). Antiserum to
1a was purchased from Santa Cruz Biochemicals
(Santa Cruz, CA). Horseradish peroxidase-labeled donkey anti-rabbit IgG
or rabbit anti-goat (SuperSignal substrate, Western Blotting; Pierce).
| |
Results |
|---|
|
|
|---|
Effect of PTX on contraction and IP accumulation. PTX treatment maximally inhibited PHE-induced contractile response at a concentration of 2.5 µg/ml (Fig. 1). Higher PTX concentrations did not cause further inhibition in the responses to PHE, and KCl-induced contraction was not altered by PTX treatment (data not shown). PHE-induced IP accumulation was also inhibited (52 ± 8%) by 2.5 µg/ml PTX treatment (Fig. 2).
|
|
Coupling of G proteins and
1-ARs.
The
possibility that
1-ARs directly couple to G
proteins was tested by coimmunoprecipitation of
1-ARs with anti-G
protein antibodies. We have previously shown by immunoblot analysis the presence of single bands for G
o (39 kDa),
G
i (41 kDa), and G
q
(42 kDa) and two bands for G
s (45 and 52 kDa) in aortic membranes (15, 19). The results summarized in Fig. 3 demonstrate that antisera against
G
q and G
o but not G
s or G
i, at
dilutions of 1:200, precipitated specific
1-AR
binding sites labeled by the selective
1-AR
ligand [125I]HEAT. To confirm the specificity
of the immunoprecipitation, the precipitates obtained using
G
q and G
o antisera
were subjected to immunoblot analyses. G
q and
G
o antisera selectively precipitated the
respective proteins (data not shown). The coupling of
G
proteins to
1-AR
subtypes
1a,
1b, and
1d was investigated by monitoring the
G
proteins that were coimmunoprecipitated with
specific antisera directed against the
1-AR
subtypes. Immunoprecipitates of the
1-AR
subtypes derived from 400 µg of solubilized aortic membranes were
separated on SDS-polyacrylamide gels and blotted with antibodies
against the G
proteins. Fig.
4, A and B, illustrates that
1a-,
1b-, and
1d-AR antibodies coimmunoprecipitated
G
q protein, whereas the
1b-AR antibody also immunoprecipitated
G
o protein. Densitometric analysis of the
results indicate that ~4.5-6% of membrane
G
q was found to be associated with
1a-,
1b-, and
1d-ARs, whereas only 2.8% of
G
o was linked to
1b-AR. The specificity of the anti-receptor
antisera and the effectiveness of the immunoprecipitation are presented
in Fig. 5. The figure demonstrates that
the antiserum for each of the receptor subtypes completely and
selectively precipitated the respective protein. Furthermore,
incubation of aortic membranes with 1 µM PHE was found to
increase [125I]HEAT binding in
immunoprecipitates of G
q and
G
o proteins by 370% and 350%, respectively
(Fig. 6). These receptor
stimulation-induced increases in receptor/G
coupling were inhibited 70-80% by an equimolar concentration of the
1-AR antagonist prazosin (Fig. 6). Thus, the
data indicate that in aortic membranes, the
1a- and
1d-ARs are
coupled to G
q protein and the
1b-AR subtype is linked to both
G
q and G
o proteins.
|
|
|
|
Receptor-activated palmitoylation of G
proteins.
To further examine the coupling of
1-AR to G
proteins,
PHE-stimulated palmitoylation of G
proteins
was assessed. Incubation of aortic membranes with PHE resulted in
significant increases in [3H]palmitoylation of
G
q and G
o proteins
(Fig. 7) without affecting
G
s and G
i proteins.
In addition, pretreatment of membranes with 1 µM of the
1-AR antagonist prazosin blocked the
PHE-stimulated incorporation of palmitic acid into
G
q and G
o proteins by
76% and 73%, respectively (Fig. 7). These results therefore support
the above data, which indicate that in aorta of 1-month-old Fischer 344 rats,
1-ARs are coupled to both
G
q and G
o proteins.
|
| |
Discussion |
|---|
|
|
|---|
Activation of PLC and increased intracellular
Ca2+ are important elements of
1-AR-mediated signaling, which result in the
contractile response of vascular smooth muscle (20, 21). Despite
considerable progress in elucidating the structure and signaling
mechanisms of
1-ARs, it is not clear which G
protein or proteins are responsible for
1-AR-mediated effects in blood vessels. Many G
protein-coupled receptors were shown to activate PLC and increase the
intracellular concentration of inositol-(1,4,5)-trisphosphate that
eventually lead to vasoconstriction. Two
1-AR-mediated pathways are known to activate
PLC and to produce vascular contraction based on their sensitivity to
PTX (5, 22). The
1a,
1b, and
1d subtypes of the
1-AR have been shown to activate PLC in
transfected COS-7 cells via coupling to the PTX-insensitive G proteins
Gq
/G11
(5). On the
other hand, several studies have shown that PTX pretreatment only
partially inhibits
1-AR-mediated contraction in blood vessels (6, 7), implicating the existence of
1-ARs that are linked to a PTX-sensitive G
protein in vessels. G
o protein was proposed to
be that PTX-sensitive G protein based on the observation that
1b-ARs, expressed in Xenopus
laevis oocytes, use Go protein in
activating PLC-mediated Cl
current (22, 23).
The current study confirms the observation that PTX partially inhibits
both
1-AR-elicited contraction and IP
accumulation in the aorta and suggests that both PTX-sensitive and
-insensitive G proteins are involved in
1-AR-mediated signal transduction in vascular
smooth muscle. To identify these G proteins, we coimmunoprecipitated
1-ARs with their associated G proteins in the
rat aorta. Specific antiserum directed against
G
q protein coimmunoprecipitated
1-ARs that are specifically labeled by
[125I]HEAT, suggesting a linkage between
1-AR and G
q protein. Antiserum specific for G
o also
coimmunoprecipitated [125I]HEAT binding sites,
indicating that endogenous
1-ARs in aorta membranes also couple to G
o. These data are
therefore in agreement with previous studies that indicated functional
coupling between
1-ARs and
G
q in transfected cells (5) and between
1b-AR and G
o in
X. laevis oocytes that express these proteins (22). In the
current study, functional relevance of these linkages is also supported
by the ability of the
1-AR agonist PHE to
increase the coupling of labeled receptors with both
G
q and G
o proteins
and to stimulate palmitoylation of G
q and
G
o proteins in aortic membranes in a
prazosin-sensitive manner. Palmitoylation of G protein
subunits is
a reversible post-translational modification that is regulated by
receptor stimulation (24-26). No linkage was detected between
1-AR and Gs or
Gi proteins using either coimmunoprecipitation or
the palmitoylation approach. Thus, the data suggest that
Go, not Gi, is responsible
for the PTX-sensitive responses to
1-AR stimulation in aorta of the 1-month-old Fischer 344 rat.
It has been shown that rat aorta express three
1-AR subtypes:
1a-,
1b-, and
1d-ARs (1,
2). The expression level of these subtypes change with age, coincident
with changes in the magnitude of aortic contraction (9, 10). This
raises questions about possible differences in the functional roles of the
1-AR subtypes. Although several studies
have shown that the three subtypes are capable of stimulating the same
signal transduction pathways when they are expressed in cultured cells
(3, 4), data from the current study indicate that antisera directed
against
1a- and
1d-ARs coimmunoprecipitated
G
q protein, whereas anti-
1b-AR antiserum coimmunoprecipitated both
G
q and G
o proteins.
Furthermore, stimulation of
1-AR with PHE
elicited an increase in the coupling of
1-ARs
to both G
q and G
o proteins. Because G proteins determine the specificity and functional diversity of downstream intracellular effectors, identification of the
interaction of a particular
1-AR subtype with
its G proteins represents an important step in unraveling the signal
transduction cascades by which specific
1-AR
subtypes exert their effects.
In summary, the current results suggest that
1-ARs are coupled to the PTX-insensitive
G
q and the PTX-sensitive
G
o in aorta derived from 1-month-old Fischer
344 rat. These G proteins therefore seem to couple to PLC and to
mediate
1-AR-stimulated contraction. It has
been shown that the three subtypes of the
1-AR
activate PLC and cause increases in inositol trisphosphate level
through G
q/G
11
proteins (5). This and a previous study (22) demonstrate that
1b-ARs stimulate PLC by coupling, in addition,
to the PTX-sensitive G
o protein. The ultimate definition of the coupling of
1-AR subtypes
with specific G
proteins will help to
understand the functional roles of the different
1-AR subtypes. This study for the first time
demonstrates the specific coupling between
1-AR subtypes and G
proteins in vascular smooth muscle membranes and implicates these G
proteins in coupling of
1-AR subtypes to the
contractile response elicited by
1-AR
stimulation in 1-month-old Fischer 344 rat aorta.
| |
Acknowledgments |
|---|
The authors thank Dr. H. Ongun Onaran for critical review of the manuscript.
| |
Footnotes |
|---|
Received March 31, 1997; Accepted September 9, 1997
This work was supported by the American Heart Association, Southeastern Pennsylvania and Delaware Affiliates; United States Public Health Service Grants AG07700, AG14510, and AG13282 (Nathan Shock Center of Excellence); Allegheny Health Education and Research Foundation; and Turkish Scientific Council Grant TUBITAK-SBAG 1634.
Send reprint requests to: Eitan Friedman, Ph.D., Division of Molecular Pharmacology, MCP-Hahnemann School of Medicine, Allegheny University of the Health Sciences, 3200 Henry Avenue, Philadelphia, PA 19129. E-mail: friedmane{at}auhs.edu
| |
Abbreviations |
|---|
AR, adrenoceptor;
PHE, phenylephrine;
NE, norepinephrine;
IP, inositol phosphate;
PTX, pertussis toxin;
PLC, phospholipase C;
[125I]HEAT, 2-[
-(4-hydroxy-3-[125I]iodophenyl)ethylaminomethyl]tetralone;
PSS, physiological salt solution;
PBS, phosphate-buffered saline;
TBS, Tween-20 containing phosphate-buffered saline;
SDS, sodium dodecyl
sulfate;
ECL, enhanced chemiluminescence;
HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid;
ANOVA, analysis of
variance.
| |
References |
|---|
|
|
|---|
| 1. |
Ping, P. and
J. E. Faber.
Characterization of 1-adrenoceptor gene expression in arterial and venous smooth muscle.
Am. J. Physiol.
265:H1501-H1509 (1993) |
| 2. |
Piascik, M. T.,
M. S. Smith,
E. E. Soltis, and
D. M. Perez.
Identification of the mRNA for the novel 1d-adrenoceptor and two other 1-adrenoceptors in vascular smooth muscle.
Mol. Pharmacol.
46:30-40 (1994)[Abstract].
|
| 3. |
Minneman, K. P. and
T. A. Esbenshade.
1-Adrenergic receptor subtypes.
Annu. Rev. Pharmacol. Toxicol.
34:117-133 (1994)[Medline].
|
| 4. | Bylund, D. B., D. C. Eikenberg, J. P. Hieble, S. Z. Salomon, R. L. Lefkowitz, K. P. Minneman, P. B. Molinof, R. R. Ruffolo, and U. Trendelenburg. IV. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46:121-136 (1994)[Medline]. |
| 5. |
Wu, D,
A. Katz,
A. H. Lee, and
M. I. Simon.
Activation of phospholipase C by 1-adrenergic receptors is mediated by the subunits of Gq family.
J. Biol. Chem.
36:25798-25802 (1992).
|
| 6. | Boonen, H. C. M. and J. G. R. De Mey. G-proteins are involved in contractile responses of isolated mesenteric resistance arteries to agonists. Naunyn-Schmiedeberg`s Arch. Pharmacol. 342:462-468 (1990)[Medline]. |
| 7. |
Nichols, A. J.,
E. D. Motley, and
R. R. Ruffolo.
Effect of pertussis toxin treatment on postjunctional alpha-1 and alpha-2 adrenoceptor function in the cardiovascular system of the pithed rat.
J. Pharmacol. Exp. Ther.
249:203-209 (1989) |
| 8. |
Liebau, S.,
J. Hohlfeld, and
U. Förstermann.
The inhibition of 1-adrenoceptor-mediated contractions of rabbit pulmonary artery by Ca2+-withdrawal, pertussis toxin and N-ethylmaleimide is dependent on agonist intrinsic efficacy.
Naunyn-Schmiedeberg`s Arch. Pharmacol.
339:496-502 (1989)[Medline].
|
| 9. | Gurdal, H., G. Cai, and M. D. Johnson. Alpha1 adrenoceptor responsiveness in the aging aorta. Eur. J. Pharmacol. 274:117-123 (1995)[Medline]. |
| 10. |
Gurdal, H.,
N. Tilakaratne,
R. D. Brown,
M. Fonseca,
E. Friedman, and
M. D. Johnson.
The expression of alpha-1 adrenoceptor subtypes changes in the rat aorta.
J. Pharmacol. Exp. Ther.
275:1656-1662 (1995) |
| 11. |
Wanstall, J. C. and
S. R. O'Donnell.
Inhibition of norepinephrine contractions by diltiazem on aorta and pulmonary artery from young and aged rats: influence of alpha-adrenoceptor reserve.
J. Pharmacol. Exp. Ther.
245:1016-1020 (1988) |
| 12. | Kendall, D. A. and S. J. Hill. Measurement of [3H]inositol phospholipid turnover, in Methods in Neurotransmitter Receptor Analysis (H. I. Yamamura, S. J Enna and M. J. Kuhar, eds.). Raven Press, New York, 69-92 (1990). |
| 13. |
Gurdal, H.,
E. Friedman, and
M. D. Johnson.
Effects of dietary restriction on the change in aortic 1-adrenoceptor mediated responses during aging in Fischer 344 rats.
J. Gerontol.
50A:B67-B71 (1995).
|
| 14. | Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254 (1976)[Medline]. |
| 15. |
Gurdal, H.,
E. Friedman, and
M. D. Johnson.
-Adrenoceptor-G s coupling decreases with age in rat aorta.
Mol. Pharmacol.
47:772-778 (1995)[Abstract].
|
| 16. |
Law, S. F.,
D. Manning, and
T. Reisine.
Identification of the subunits of GTP-binding proteins coupled to somatostatin receptors.
J. Biol. Chem.
266:17885-17897 (1991) |
| 17. |
Fonseca, M. I.,
D. Button, and
R. D. Brown.
Agonist regulation of 1b-adrenergic receptor subcellular distribution and function.
J. Biol. Chem.
270:8902-8909 (1995) |
| 18. | Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 229:680-685 (1970). |
| 19. | Johnson, M. D., Y. G. Zhou, E. Friedman, and J. Roberts. Expression of G protein subunits in the aging cardiovascular system. J. Gerontol. 50:B14-B19 (1995). |
| 20. |
Cauvin, C. and
S. Malik.
Induction of Ca++ influx and intracellular Ca++ release in isolated rat aorta and mesenteric resistance vessels by norepinephrine activation of alpha-1 receptors.
J. Pharmacol. Exp. Ther.
238:224-231 (1984) |
| 21. | Suematsu, E., M. Hirata, T. Hashimato, and H. Kuriyama. Inositol 1,4,5-trisphosphate releases Ca2+ from intracellular store sites in skinned single cells of porcine coronary artery. Biochem. Biophys. Res. Commun. 120:481-485 (1984)[Medline]. |
| 22. |
Blitzer, R. D.
Omri, M. De Vivo, D. J. Carty, R. T. Premon, J. Codina, L. Brinbaumer, S. Cotecchia, M. G. Caron, R. J. Lefkowitz, E. M. Landau, and R. Iyengar. Coupling of the expressed 1B-adrenergic receptor to the phospholipase C pathway in Xenopus oocytes: the role of Go.
J. Biol. Chem.
268:7532-7537 (1993) |
| 23. |
Padrell, E.,
D. J. Carty,
T. M. Moriarty,
J. D. Hildebrant,
E. M. Landau, and
R. Iyengar.
Two forms of bovine brain Go that stimulate the inositol trisphosphate-mediated Cl currents in Xenopus oocytes: distinct guanine nucleotide binding properties.
J. Biol. Chem.
266:9771-9777 (1991) |
| 24. |
Casey, P. J.
Protein lipidation in cell signaling.
Science (Washington D. C.)
268:221-225 (1995) |
| 25. |
Wedegaertner, P. B.,
P. T. Wilson, and
H. R. Bourne.
Lipid modifications of trimeric G proteins.
J. Biol. Chem.
270:503-506 (1995) |
| 26. |
Mumby, S. M.,
C. Kleuss, and
A. G. Gilman.
Receptor regulation of G-protein palmitoylation.
Proc. Natl. Acad. Sci. USA
91:2800-2804 (1994) |
This article has been cited by other articles:
![]() |
J. O-Uchi, H. Sasaki, S. Morimoto, Y. Kusakari, H. Shinji, T. Obata, K. Hongo, K. Komukai, and S. Kurihara Interaction of {alpha}1-Adrenoceptor Subtypes With Different G Proteins Induces Opposite Effects on Cardiac L-type Ca2+ Channel Circ. Res., June 6, 2008; 102(11): 1378 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gallego, R. Setien, L. Puebla, M. d. C. Boyano-Adanez, E. Arilla, and O. Casis {alpha}1-Adrenoceptors stimulate a G{alpha}s protein and reduce the transient outward K+ current via a cAMP/PKA-mediated pathway in the rat heart Am J Physiol Cell Physiol, March 1, 2005; 288(3): C577 - C585. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Barki-Harrington, C. Perrino, and H. A Rockman Network integration of the adrenergic system in cardiac hypertrophy Cardiovasc Res, August 15, 2004; 63(3): 391 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Papoucheva, A. Dumuis, M. Sebben, D. W. Richter, and E. G. Ponimaskin The 5-Hydroxytryptamine(1A) Receptor Is Stably Palmitoylated, and Acylation Is Critical for Communication of Receptor with Gi Protein J. Biol. Chem., January 30, 2004; 279(5): 3280 - 3291. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vicentic, A. Robeva, G. Rogge, M. Uberti, and K. P. Minneman Biochemistry and Pharmacology of Epitope-Tagged alpha 1-Adrenergic Receptor Subtypes J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 58 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Seasholtz, G. Cai, H.-Y. Wang, and E. Friedman Signal Transduction in Smooth Muscle: Selected Contribution: Effects of ischemia-reperfusion on vascular contractility and {alpha}1-adrenergic-receptor signaling in the rat tail artery J Appl Physiol, August 1, 2001; 91(2): 1004 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guimaraes and D. Moura Vascular Adrenoceptors: An Update Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. S. Chang, J. P. Tam, and E. Sanders-Bush Dissecting Intracellular Signaling Pathways with Membrane-Permeable Peptides Sci. Signal., August 29, 2000; 2000(47): pl1 - pl1. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Chen and D. R. Manning Regulation of Galpha i Palmitoylation by Activation of the 5-Hydroxytryptamine-1A Receptor J. Biol. Chem., July 28, 2000; 275(31): 23516 - 23522. [Abstract] [Full Text] [PDF] |
||||
| ||||||